Delivery of medical equipment and reagents along with equipment leasing (9 parts) | Tenderlake

Delivery of medical equipment and reagents along with equipment leasing (9 parts)

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
10 December 2025
Closing Date:
15 January 2026
Location(s):
PL418 Poznański (PL Poland/POLSKA)
Description:
Leasing and delivery of various medical equipment and reagents, including devices for nucleic acid isolation, PCR thermal cyclers, automatic pipettes, and genetic analysis tools.

Delivery of medical equipment and reagents along with equipment leasing (9 parts)


LOT-0001
Leasing of a device for automatic isolation of nucleic acids.
Leasing of a device for automatic isolation of DNA/RNA nucleic acids (A) along with the necessary reagents and consumables for isolation from blood, vaginal swabs, cervix, urethra, anus, urine samples, cerebrospinal fluid, amniotic fluid, soft tissues (chorion), paraffin blocks (B)


LOT-0002
Leasing of a real-time PCR thermal cycler (A) along with the supply of reagents and consumables for analysis (B):.
Leasing of a real-time PCR thermal cycler (A) along with the supply of reagents and consumables for analysis (B): Chlamydia Trachomatis, Cytomegalovirus, urogenital panels (Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Trichomonas vaginalis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis),


LOT-0003
Delivery of automatic pipettes.
Delivery of automatic pipettes with adjustable volume 0.5-10 mL; 10-100 mL; 100-1000 mL


LOT-0004
Delivery of high-performance reagent kits and materials for DNA isolation.
Delivery of high-performance reagent kits and materials for DNA isolation from amniotic fluid, blood, and tissues for diagnostics using microarray methods


LOT-0005
Delivery of high-performance kits for purification of isolated genomic DNA.
Delivery of high-performance kits for purification of isolated genomic DNA for diagnostics using microarray methods


LOT-0006
Delivery of reagents for the analysis of 11 mutations in the BRCA1, CHEK2, and PALB2 genes.
Delivery of reagents for the analysis of 11 mutations in the BRCA1, CHEK2, and PALB2 genes recommended as part of the "National Cancer Prevention Program" using a modified Sanger sequencing method,


LOT-0007
Delivery of reagents for the analysis of 6 key mutations in the POLE gene.
Delivery of reagents for the analysis of 6 key mutations in the POLE gene A456P, P286R, V411L (G>C) and (G>T), S297F, S459F for a period of 24 months


LOT-0008
Purchase of a genetic analyzer.
Purchase of a genetic analyzer with CE IVD certification, for versatile genetic analysis, based on capillary electrophoresis technology with 8 capillaries, integrated with data collection software.


LOT-0009
Delivery of reagents for aneuploidy analysis using QF-PCR as well as delivery of reagents for the diagnosis of mutations in the AZF, CFTR genes and for the diagnosis of thrombophilia: Factor V Leiden G1691A/R506Q, Factor V R2 H1299R, Prothrombin/Factor II G20210A, MTHFR (C677T), MTHFR (A1298C), PAI-1/SERPINE1 4G/5G using QF-PCR..
Delivery of reagents for aneuploidy analysis using QF-PCR as well as delivery of reagents for the diagnosis of mutations in the AZF, CFTR genes and for the diagnosis of thrombophilia: Factor V Leiden G1691A/R506Q, Factor V R2 H1299R, Prothrombin/Factor II G20210A, MTHFR (C677T), MTHFR (A1298C), PAI-1/SERPINE1 4G/5G using QF-PCR.

The Buyer:
GINEKOLOGICZNO - POŁOŻNICZY SZPITAL KLINICZNY IM. HELIODORA ŚWIĘCICKIEGO UNIWERSYTETU MEDYCZNEGO IM. KAROLA MARCINKOWSKIEGO W POZNANIU
Additional information:
Link:
Download Full Notice as PDF
Link:
View Full Notice
Link:
Additional document: PN-113/25
CPV Code(s):
33696000 - Reagents and contrast media
38000000 - Laboratory, optical and precision equipments (excl. glasses)